Modes of Presentation of Patients with Suspected Prostate Cancer Disease in Two Nigerian Semi-Urban Referral Health Facilities
Asian Oncology Research Journal,
Background: Prostate cancer is the most commonly diagnosed cancer in men and the second leading cause of cancer mortality after lung cancer worldwide. The incidence of this disease is high among men of African descent. The modes of presentation of patients with prostate cancer are varied. In this paper, we present an overview of the modes of clinical presentation of men with suspected prostate cancer and their relationship with the histological diagnosis of prostate cancer.
Materials and Methods: This was a prospective and hospital‑based study. Patients who had a prostate biopsy done due to elevated serum prostate‑specific antigen (PSA) levels, abnormal digital rectal examination (DRE) findings of the prostate gland, or a combination of both were included in this study. Their biodata, modes of presentation, and other clinical and histological information were recorded in a pro forma. Data analysis was done using the statistical programming for social sciences (SPSS) version 21. For all statistical tests, P < 0.05 was regarded as significant.
Results: One hundred and thirty-two patients were recruited into this study. The mean age of the patients was 69.75 ± 9.15 years. Most participants (75%) were in their seventh and eighth decades of life. The mean serum PSA level was 35.01±8.52ng/ml (range: 6 to 164ng/ml), while the mean prostate volume was 101.4 ± 91.4 ml (range: 10–635ml).
Lower urinary tract symptoms (LUTS) were the most common mode of presentation accounting for 97.7% (n=129) of the cases studied. This was followed by haematuria (34.1%, n=45), low back pain (25.8%, n=34), weight loss (22.7%, n=30), and paraplegia/paraparesis (7.6%, n=10). Bone pains and paraparesis/paraplegia significantly correlated with the diagnosis of adenocarcinoma of the prostate.
Conclusion: The majority of men with suspected prostate cancer were found to be symptomatic at presentation. The modes of presentation were varied with LUTS being the most common. Low back pain and paraparesis/paraplegia were positive predictors of prostate cancer disease.
- Prostate cancer
- modes of presentation
- health facility
- prostate specific antigen
How to Cite
Pietro GD, Chornokur G, Kumar NB, Davis C, Park, JY. Racial differences in the diagnosis and treatment of prostate cancer. Int Neurourol J 2016;20:S112–S119.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7-30.
Miller EA, Pinsky PF, Black A, Andriole, GL, Pierre-Victor D. Secondary prostate cancer screening outcomes by race in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Screening Trial. Prostate. 2018;78:830-8.
Sim HG, Cheng CW. Changing demography of prostate cancer in Asia. Eur J Cancer. 2005;41:834-5.
Yawe KT, Tahir MB, Naggada HA. Prostate cancer in Maiduguri. West Afr J Med. 2006;25:298-302.
Eke N, Sapira MK. Prostate cancer in port harcourt, Nigeria: features and outcome. Niger J Surg Res. 2002;4:34-44.
Litwin MS, Tan HJ. The diagnosis and treatment of prostate cancer: A review. JAMA 2017;317:2532-42.
Ekwere PD, Egbe SN. The changing pattern of prostate cancer in Nigerians: current status in the southeastern states. J Natl Med Assoc. 2002;94:619-27.
Badmus TA, Adesunkanmi AR, Yusuf BM, Oseni GO, Eziyi AK, et al. Burden of prostate cancer in southwestern Nigeria. Urology. 2010;76:412-6.
Elabbady A, Eid A, Fahmy A, Kotb AF. Pattern of prostate cancer presentation among the Egyptian population: A study in a single tertiary care center. Cent European J Urol. 2014;67:351-6.
Ugare GU, Bassey I, Essiet A, Bassey OO, The causes and incidence of urinary retention in the University of Calabar Teaching Hospital, Calabar. Int J Trop Surg. 2009;3:78-83.
Soyebi KO, Awosanyo GOG. Causes of obstructive uropathy at the Lagos University Teaching Hospital, Lagos. Nig Q J Hosp Med. 1996;6:173-7.
Brown CT, O'Flynn E, Van Der Meulen J, Newman S, Mundy AR, Emberton M. The fear of prostate cancer in men with lower urinary tract symptoms: should symptomatic men be screened? BJU Int. 2003;91:30-2.
Young JM, Muscatello DJ, Ward JE. Are men with lower urinary tract symptoms at increased risk of prostate cancer? A systematic review and critique of the available evidence. BJU Int. 2000;85:1037-48.
Ogbetere FE, Irekpita E. Detection rate of prostate cancer following 12-core extended biopsy in a Semi-urban Nigerian Tertiary Hospital. Urol Ann. 2021;13:150-5.
Ramyl VM, Dakum NK, Liman UH, Udeh EI. The Management of Prostatic Haematuria. Niger J Med. 2008;17:439-42.
Orakwe JC, Okafor PIS. Emergency transvesical prostatectomy: A review of 50 cases. Trop J Med Res. 2002;16:46-9.
De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study. Lancet Oncol. 2014;15:23-34.
Ojewola RW, Tijani KH, Jeje EA, Anunobi CC, Ogunjimi MA, Ezenwa EV, et al. Is extended biopsy protocol justified in all patients with suspected prostate cancer? Niger J Clin Pract. 2012;15:315 9.
Dawam D, Rafindadi AH, Kalayi GD. Benign prostatic hyperplasia and prostate carcinoma in native Africans. BJU Int. 2000;85:1074-7.
Shenoy D, Packianathan S, Chen AM, Vijayakumar S. Do African-American men need separate prostate cancer screening guidelines? BMC Urol. 2016;16:19.
Miller DC, Hafez MD, Stewart A, Momtie JE, Wei JT. Prostate carcinoma presentation, diagnosis, and staging. Cancer. 2003;98:1169- 78.
Abstract View: 363 times
PDF Download: 130 times